Skip to main content
Home

Top menu infoNTD

  • About InfoNTD
  • News & Events
  • e-learning.infoNTD.org
Home

Main navigation InfoNTD

  • NTDs [14]
    • Buruli ulcer
    • Chagas disease
    • Dracunculiasis
    • Human African trypanosomiasis
    • Leishmaniasis
    • Leprosy
    • Lymphatic filariasis
    • Mycetoma
    • Onchocerciasis
    • Schistosomiasis
    • Snakebite envenoming
    • Soil-transmitted helminthiasis
    • Trachoma
    • Yaws
  • Cross-cutting issues [13]
    • Data management & analysis [3]
      • Data collection and reporting
      • Mapping
      • Indicators
    • Integrated wound management
    • Capacity strengthening
    • Management of disease complications [2]
      • Medical management
      • Surgical management
    • Prevention of disability [3]
      • Eye care
      • Self-care
      • Disability measurement
    • Physical rehabilitation [3]
      • Physical therapy
      • Orthopaedic footwear
      • Protheses, walking devices and wheelchairs
    • Stigma and mental wellbeing [1]
      • Mental wellbeing project mapping
    • Inclusion [2]
      • Community-based rehabilitation
      • Gender
    • WASH and NTDs
    • Health systems factors
    • Skin-NTDs
    • Preventive Chemotherapy
    • Health education
  • Toolkits [5]
    • Guides on Stigma and Mental Wellbeing [5]
      • Guide 1. What are health-related stigma and mental wellbeing? [8]
        • 1. What is stigma?
        • 2. Why does stigma exist?
        • 3. What are the causes of stigma?
        • 4. Who stigmatises?
        • 5. How does it feel to experience stigma?
        • 6. What are the effects of stigma?
        • 7. Effects of stigma and discrimination on mental wellbeing
        • Annex Guide 1
      • Guide 2. How to reduce the impact of stigma [7]
        • 1. From undetected disease to diagnosis to support
        • 2. Individual-level interventions
        • 3. Group-level interventions
        • 4. Family-level interventions
        • 5. Referral
        • 6. Further reading
        • Annexes Guide 2
      • Guide 3. How to reduce sources of stigma [6]
        • 1. Background to the design of a stigma-reduction intervention
        • 2. Identifying the sources of stigma
        • 3. Targeting an intervention
        • 4. Inclusion of affected persons and champions in interventions
        • 5. Interventions by source type
        • Annexes Guide 3
      • Guide 4. How to assess health-related stigma and mental wellbeing [9]
        • 1. What is the purpose of the assessment?
        • 2. What approach would best fit your purpose and context?
        • 3. Quantitative assessment methods
        • 4. Qualitative assessment methods
        • 5. Assessments using mixed methods
        • 6. Developing qualitative methods from scratch
        • 7. How do you conduct a stigma assessment?
        • 8. How to interpret and report your findings
        • Annexes Guide 4
      • Glossary
    • Perception Study Toolkit (PST)
    • NTD Morbidity and Disability Measurement Toolkit [15]
      • CHIEF
      • Clinical Profile
      • EMIC affected persons
      • EMIC-CS Community Stigma
      • Participation Scale
      • Patient Health Questionnaire (PHQ-9)
      • 5-Question Stigma Indicators
      • Salsa Scale
      • SARI Stigma Scale
      • SDS Social Distance Scale
      • SRQ Self-reporting Questionnaire
      • Warwick-Edinburgh Mental Wellbeing Scale (WEMWBS)
      • WGQ Washington Group Questions
      • WHODAS
      • WHOQOL-BREF
    • NTD Toolbox
    • CBM's Community Mental Health Good Practice Guides
  • Online courses

Top menu infoNTD

  • About InfoNTD
  • News & Events
  • e-learning.infoNTD.org
Visit our e-learning platform
Search resources Search in Practical Materials, Publications, Organizations, Online Course and more
Publication

Women’s access to Water for sustainable development in nigeria: draWing lessons from south africa’s Water-reneWable techniques

Adeniyi O, Adeniyi A. AFRICAN SUN MeDIA. Journal for Juridical Science. 2020;
Download PDF
Publication

Developing a research question: A research primer for low- and middle-income countries

Mitchell RD, O'Reilly GM, Phillips GA, et al. Elsevier BV. African Journal of Emergency Medicine. 2020;
Download PDF
Publication

Persons with onchocerciasis-associated epilepsy and nodding seizures have a more severe form of epilepsy with more cognitive impairment and higher levels of Onchocerca volvulus infection.

Abd-Elfarag G, Carter J, Raimon S, et al. Epileptic disorders : international epilepsy journal with videotape. 2020;
Publication

Evaluation of morbidity in Schistosoma mansoni-positive primary and secondary school children after four years of mass drug administration of praziquantel in western Kenya.

Abudho B, Guyah B, Ondigo B, et al. Infectious diseases of poverty. 2020; 9 (1) : 67.
Download PDF
Publication

A cross‐sectional study of dermatological conditions in rural and urban Timor‐Leste

Hao EY, Rhodes JE, Nixon RL, et al. Wiley. Australasian Journal of Dermatology. 2020;
Publication

Activity limitation and social participation restriction of people with leprosy: a cross-sectional analysis of magnitude and associated factors in a hyperendemic municipality in the state of Piauí, Brazil, 2001-2014.

Nascimento D, Novaes Ramos A, de Araújo O, et al. Epidemiologia e servicos de saude : revista do Sistema Unico de Saude do Brasil. 2020; 29 (3) : e2019543.
Download PDF
Publication

A Systematic Review and Meta-Analysis to assess the association between Urogenital Schistosomiasis and HIV/AIDS Infection.

Zirimenya L, Mahmud-Ajeigbe F, McQuillan R, et al. PLoS neglected tropical diseases. 2020; 14 (6) : e0008383.
Download PDF
Publication

Ascend West and Central Africa COVID-19 and NTDs

Molyneux DH. Ascend. 2020;
Download PDF
Publication

Skin Disorders in Migrants

Morrone A, Hay R, Naafs B. Springer International Publishing. 2020;
Publication

Interpretation systems, therapeutic itineraries and repertoires of leprosy patients in a low prevalence country.

Osorio-Mejía C, Falconí-Rosadio E, Acosta J. Revista peruana de medicina experimental y salud publica. 2020; 37 (1) : 25-31.

Pagination

  • Previous page ‹ ‹ Previous
  • …
  • Page 513
  • Page 514
  • Page 515
  • Page 516
  • Current page 517
  • Page 518
  • Page 519
  • Page 520
  • Page 521
  • …
  • Next page Next › ›
  • Last page Last » »
Subscribe to

Quick Links

  • Toolbox
  • Publications
  • Organizations
  • NTDs

Support

  • Contact
  • FAQ
  • Privacy statement

Contact us infoNTD

info@InfoNTD.org

(+31) 20 595 0526

     

Stay up to date with the latest developments in NTDs. We share a monthly overview via email showing a selection of the latest NTD publications and tools. 

Subscribe

Related websites:

© 2026 InfoNTD